For procurement & QA leaders

A regulated-operations platform built for how serious evaluations actually run

Q: Is Novaqis an alternative in the same evaluations as major enterprise GxP suites?

Often, yes. Buyers shortlisting regulated document management, GxP content systems, or multi-module quality platforms can evaluate Novaqis on the same functional, validation, and commercial criteria. We are a separate product; see our FAQ for how we refer to other vendors’ trademarks (identification only).

Q: Why does Novaqis sound confident versus legacy suite vendors?

Our team has spent years shipping and operating large-scale regulated quality and document platforms—so we optimize for architecture, deployment choice, and lifecycle cost we wished we could prioritize earlier. That is our opinion and experience, not a universal benchmark; your POC and IQ/OQ/PQ decide fit.

Q: What should we score in an RFP or matrix?

Use the same rigor you already use: 21 CFR Part 11 and EU Annex 11 themes, audit trails, e-signatures, release and obsolescence, training linkage, reporting boundaries, validation evidence, deployment model, and total cost of ownership—including per-user and per-site fees, AMC, platform license, and desktop authoring (e.g. Microsoft Word seats). Novaqis includes unlimited users and sites, positions license and AMC at roughly half of comparable enterprise quotes, and provides a built-in editor for daily work. We welcome structured comparisons.

Q: How does Novaqis differ from a generic ECM?

Novaqis targets pharma, biotech, and cosmetic GMP—controlled documents, accountability, inspector-ready evidence—not generic file sharing. Nova AI runs on-premises, follows your access rules, and lets administrators curate a dedicated knowledge base—OCR, plain-language reporting, and Q&A without training on your customer data.

Q: Where is the technical depth?

Start with the products hub, then DMS, LMS, QMS, BRM, Admin, Reporting, and Nova AI. For a live walkthrough, contact us—we prefer demonstrating the stack over generic slides.

Novaqis is an independent suite—platform modules for governance, documents, training, quality, batch records, reporting, and AI on your data, plus LIMS on the roadmap. Our leadership comes from years of delivering and operating large-scale GxP quality and document platforms—the same category of systems enterprises buy from the incumbent suite vendors you already know. We started Novaqis to prioritize deployment flexibility, unified audit identity, and architecture without inherited constraints—then let your matrix and POC prove the difference.

What we believe: teams that run a disciplined side-by-side will see a generational gap in how the stack feels—speed to value, ownership of data, and honesty of integration—not because we say so, but because you test it the way you already test everyone else.

Why teams put Novaqis next to the usual enterprise shortlist

Lower TCO — No per-user or per-site license fees; platform license and AMC positioned at roughly half of comparable enterprise suite quotes; built-in authoring reduces Microsoft Word seat sprawl.
Practitioner-shaped — Built by people who carried validation, releases, and production operations for regulated suites—not slideware.
One platform story — Identity, licensing, documents, training, quality events, reporting, and AI share governed boundaries so you are not re-proving a new integration every quarter.
GxP-minded — 21 CFR Part 11 and EU Annex 11 themes, ALCOA+ expectations, e-signatures—stated honestly as shared responsibility with your QA org.
Deployment you control — Run where your regulators and security model expect—not where a vendor’s tenancy model forces you.
Training & quality on one stack — LMS and QMS share the same platform as DMS; lab and batch-record directions follow without abandoning the audit vocabulary.

Use your existing matrix—we like a fair fight

Whether your incumbent is a widely adopted multi-tenant suite, a legacy DMS, or a stitched best-of-breed stack, apply the same criteria: lifecycle, obsolescence, training linkage, search, reporting boundaries, export and segregation-of-duties rules, validation packs, commercial model, and how AI touches production data. We publish module-level detail so your SMEs can map requirements without a generic deck—and we are comfortable with transparent, criteria-driven comparisons.

Novaqis DMS Admin & licensing Nova AI Novaqis LMS Novaqis QMS Reporting All products

Common questions

Is Novaqis an alternative in the same evaluations as major enterprise GxP suites?: Often, yes. Buyers shortlisting regulated document management, GxP content systems, or multi-module quality platforms can evaluate Novaqis on the same functional, validation, and commercial criteria. We are a separate product; see our FAQ for how we refer to other vendors’ trademarks (identification only).
Why does Novaqis sound confident versus legacy suite vendors?: Our team has spent years shipping and operating large-scale regulated quality and document platforms—so we optimize for architecture, deployment choice, and lifecycle cost we wished we could prioritize earlier. That is our opinion and experience, not a universal benchmark; your POC and IQ/OQ/PQ decide fit.
What should we score in an RFP or matrix?: Use the same rigor you already use: 21 CFR Part 11 and EU Annex 11 themes, audit trails, e-signatures, release and obsolescence, training linkage, reporting boundaries, validation evidence, deployment model, and total cost of ownership—including per-user and per-site fees, AMC, platform license, and desktop authoring (e.g. Microsoft Word seats). Novaqis includes unlimited users and sites, positions license and AMC at roughly half of comparable enterprise quotes, and provides a built-in editor for daily work. We welcome structured comparisons.
How does Novaqis differ from a generic ECM?: Novaqis targets pharma, biotech, and cosmetic GMP—controlled documents, accountability, inspector-ready evidence—not generic file sharing. Nova AI runs on-premises, follows your access rules, and lets administrators curate a dedicated knowledge base—OCR, plain-language reporting, and Q&A without training on your customer data.
Where is the technical depth?: Start with the products hub, then DMS, LMS, QMS, BRM, Admin, Reporting, and Nova AI. For a live walkthrough, contact us—we prefer demonstrating the stack over generic slides.

See the stack on your terms

Bring your requirements and risk questions—we will walk the live product and stay concrete.

Book a conversation Case studies Read the FAQ

A regulated-operations platform built for how serious evaluations actually run

What we believe: teams that run a disciplined side-by-side will see a generational gap in how the stack feels—speed to value, ownership of data, and honesty of integration—not because we say so, but because you test it the way you already test everyone else.

Why teams put Novaqis next to the usual enterprise shortlist

Lower TCO — No per-user or per-site license fees; platform license and AMC positioned at roughly half of comparable enterprise suite quotes; built-in authoring reduces Microsoft Word seat sprawl.

Practitioner-shaped — Built by people who carried validation, releases, and production operations for regulated suites—not slideware.

One platform story — Identity, licensing, documents, training, quality events, reporting, and AI share governed boundaries so you are not re-proving a new integration every quarter.

GxP-minded — 21 CFR Part 11 and EU Annex 11 themes, ALCOA+ expectations, e-signatures—stated honestly as shared responsibility with your QA org.

Deployment you control — Run where your regulators and security model expect—not where a vendor’s tenancy model forces you.

Training & quality on one stack — LMS and QMS share the same platform as DMS; lab and batch-record directions follow without abandoning the audit vocabulary.

Use your existing matrix—we like a fair fight

Common questions

Is Novaqis an alternative in the same evaluations as major enterprise GxP suites?

Often, yes. Buyers shortlisting regulated document management, GxP content systems, or multi-module quality platforms can evaluate Novaqis on the same functional, validation, and commercial criteria. We are a separate product; see our FAQ for how we refer to other vendors’ trademarks (identification only).

Why does Novaqis sound confident versus legacy suite vendors?

Our team has spent years shipping and operating large-scale regulated quality and document platforms—so we optimize for architecture, deployment choice, and lifecycle cost we wished we could prioritize earlier. That is our opinion and experience, not a universal benchmark; your POC and IQ/OQ/PQ decide fit.

What should we score in an RFP or matrix?

Use the same rigor you already use: 21 CFR Part 11 and EU Annex 11 themes, audit trails, e-signatures, release and obsolescence, training linkage, reporting boundaries, validation evidence, deployment model, and total cost of ownership—including per-user and per-site fees, AMC, platform license, and desktop authoring (e.g. Microsoft Word seats). Novaqis includes unlimited users and sites, positions license and AMC at roughly half of comparable enterprise quotes, and provides a built-in editor for daily work. We welcome structured comparisons.

How does Novaqis differ from a generic ECM?

Novaqis targets pharma, biotech, and cosmetic GMP—controlled documents, accountability, inspector-ready evidence—not generic file sharing. Nova AI runs on-premises, follows your access rules, and lets administrators curate a dedicated knowledge base—OCR, plain-language reporting, and Q&A without training on your customer data.

Where is the technical depth?

Start with the products hub, then DMS, LMS, QMS, BRM, Admin, Reporting, and Nova AI. For a live walkthrough, contact us—we prefer demonstrating the stack over generic slides.